Olink Explore - Model 384 -II - Oncology & Oncology Protein Biomarker Panel

These panels contain both established oncology-related protein biomarkers and exploratory biomarkers. The panel comprises human proteins that participate in biological mechanisms that are central to the initiation and progression of cancer, e.g. angiogenesis, cell communication, cellular metabolic processes, apoptosis, cell proliferation/differentiation. Many of the assays also address proteins that are defined as relevant for cancer according to DisGenNet, including multiple markers associated with carcinogenesis, tumor progression, solid tumors, and recurrent tumors.

The Explore 384 Oncology and Oncology II panels offer simultaneous analysis of 384 protein biomarkers using just 1 µL of biological sample, and all assays are subject to Olink’s strict technical validation and Quality Control procedures.